David G. Levitt

7.4k total citations · 1 hit paper
123 papers, 5.4k citations indexed

About

David G. Levitt is a scholar working on Molecular Biology, Physiology and Biomedical Engineering. According to data from OpenAlex, David G. Levitt has authored 123 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 25 papers in Physiology and 20 papers in Biomedical Engineering. Recurrent topics in David G. Levitt's work include Diet and metabolism studies (15 papers), Ion channel regulation and function (14 papers) and Nanopore and Nanochannel Transport Studies (11 papers). David G. Levitt is often cited by papers focused on Diet and metabolism studies (15 papers), Ion channel regulation and function (14 papers) and Nanopore and Nanochannel Transport Studies (11 papers). David G. Levitt collaborates with scholars based in United States, United Kingdom and France. David G. Levitt's co-authors include Michael D. Levitt, Leonard Banaszak, John A. Dani, Julie Furne, Joseph Hautman, E. Radford Decker, Michael D. Levitt, Michael D. Hall, Thomas W. Schnider and Michael Levitt and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David G. Levitt

123 papers receiving 5.2k citations

Hit Papers

Human serum albumin homeostasis: a new look at the roles ... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements
    2016 464 citations David G. Levitt, Michael D. Levitt International Journal of General Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Levitt United States 43 2.3k 777 569 548 427 123 5.4k
Dov Lichtenberg Israel 44 4.4k 1.9× 397 0.5× 637 1.1× 387 0.7× 282 0.7× 174 7.3k
Jürgen E. Schneider United Kingdom 47 2.6k 1.1× 612 0.8× 606 1.1× 895 1.6× 315 0.7× 305 8.5k
Britton Chance United States 47 3.3k 1.4× 1.7k 2.2× 1.1k 1.9× 691 1.3× 290 0.7× 268 8.2k
Shiro Maeda Japan 44 2.3k 1.0× 337 0.4× 568 1.0× 587 1.1× 365 0.9× 261 6.6k
Mitsuru Tanaka Japan 35 1.4k 0.6× 551 0.7× 736 1.3× 302 0.6× 249 0.6× 255 4.9k
David R. Bevan United States 46 3.2k 1.4× 605 0.8× 1.1k 1.9× 1.3k 2.4× 322 0.8× 280 7.7k
Akira Ishii Japan 43 1.7k 0.7× 589 0.8× 376 0.7× 568 1.0× 873 2.0× 586 8.5k
R. Michael Garavito United States 50 6.0k 2.6× 409 0.5× 771 1.4× 651 1.2× 736 1.7× 105 13.0k
Young C. Kim United States 41 3.2k 1.4× 525 0.7× 359 0.6× 263 0.5× 904 2.1× 143 5.9k
Masaru Suzuki Japan 38 1.4k 0.6× 556 0.7× 1.1k 2.0× 320 0.6× 618 1.4× 408 6.8k

Countries citing papers authored by David G. Levitt

Since Specialization
Citations

This map shows the geographic impact of David G. Levitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Levitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Levitt more than expected).

Fields of papers citing papers by David G. Levitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Levitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Levitt. The network helps show where David G. Levitt may publish in the future.

Co-authorship network of co-authors of David G. Levitt

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Levitt. A scholar is included among the top collaborators of David G. Levitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Levitt. David G. Levitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levitt, David G. & Michael D. Levitt. (2017). Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clinical and Experimental Gastroenterology. Volume 10. 147–168. 84 indexed citations
2.
Levitt, David G. & Michael D. Levitt. (2016). Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. International Journal of General Medicine. Volume 9. 229–255. 464 indexed citations breakdown →
3.
4.
Levitt, David G.. (2009). PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial. BMC Research Notes. 2(1). 158–158. 18 indexed citations
5.
Levitt, David G., Steven B. Heymsfield, Richard N. Pierson, Sue A. Shapses, & John G. Kral. (2007). Physiological models of body composition and human obesity. Nutrition & Metabolism. 4(1). 19–19. 21 indexed citations
6.
Levitt, David G. & Rik C. Schoemaker. (2006). Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. PubMed. 6(1). 1–1. 41 indexed citations
7.
Levitt, David G. & Thomas W. Schnider. (2005). Human physiologically based pharmacokinetic model for propofol. BMC Anesthesiology. 5(1). 4–4. 59 indexed citations
8.
Levitt, David G.. (2004). Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference. PubMed. 4(1). 2–2. 24 indexed citations
9.
Levitt, David G.. (2003). The pharmacokinetics of the interstitial space in humans. PubMed. 3(1). 3–3. 79 indexed citations
10.
11.
12.
Levitt, David G.. (1999). Modeling of Ion Channels. The Journal of General Physiology. 113(6). 789–794. 61 indexed citations
13.
Levitt, David G., et al.. (1997). Calibration of a COTS Integration Cost Model Using Local Project Data. 2 indexed citations
14.
Levitt, David G.. (1991). General continuum theory for multiion channel. II. Application to acetylcholine channel. Biophysical Journal. 59(2). 278–288. 42 indexed citations
15.
Levitt, David G.. (1991). General continuum theory for multiion channel. I. Theory. Biophysical Journal. 59(2). 271–277. 64 indexed citations
16.
Dani, John A. & David G. Levitt. (1990). Diffusion and kinetic approaches to describe permeation in ionic channels. Journal of Theoretical Biology. 146(3). 289–301. 31 indexed citations
17.
Levitt, David G. & E. Radford Decker. (1988). Electrostatic radius of the gramicidin channel determined from voltage dependence of H+ ion conductance. Biophysical Journal. 53(1). 33–38. 30 indexed citations
18.
Levitt, David G., et al.. (1983). Reflection coefficient and permeability of urea and ethylene glycol in the human red cell membrane.. The Journal of General Physiology. 81(2). 239–253. 62 indexed citations
19.
Levitt, David G., et al.. (1983). Urea and ethylene glycol-facilitated transport systems in the human red cell membrane. Saturation, competition, and asymmetry.. The Journal of General Physiology. 81(2). 221–237. 101 indexed citations
20.
Levitt, David G., et al.. (1983). Osmotic water permeability of the human red cell. Dependence on direction of water flow and cell volume.. The Journal of General Physiology. 81(2). 213–220. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dov Lichtenberg Breakdown of academic impact, for papers by Jürgen E. Schneider Breakdown of academic impact, for papers by Britton Chance Breakdown of academic impact, for papers by Shiro Maeda Breakdown of academic impact, for papers by Mitsuru Tanaka Breakdown of academic impact, for papers by David R. Bevan Breakdown of academic impact, for papers by Akira Ishii Breakdown of academic impact, for papers by R. Michael Garavito Breakdown of academic impact, for papers by Young C. Kim Breakdown of academic impact, for papers by Masaru Suzuki
Rankless by CCL
2026